MENLO THERAPEUTICS INC - COM (MNLO)

CUSIP: 586858102

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
16,310,413
Share change
+2,054,652
Total reported value
$160,655,990
Price per share
$9.85
Number of holders
51
Value change
+$24,813,495
Number of buys
35
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 586858102?
CUSIP 586858102 identifies MNLO - MENLO THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MENLO THERAPEUTICS INC - COM (MNLO) as of Q3 2018

As of 30 Sep 2018, MENLO THERAPEUTICS INC - COM (MNLO) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,310,413 shares. The largest 10 holders included Vivo Capital, LLC, JANUS HENDERSON GROUP PLC, venBio Partners L.P., Novo Holdings A/S, GREAT POINT PARTNERS LLC, FIRST MANHATTAN CO, BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, and BlackRock Inc.. This page lists 51 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.